Could High-Dose Biotin Be Used as a Treatment for Multiple Sclerosis?

Wendy Henderson avatar

by Wendy Henderson |

Share this article:

Share article via email

High-dose biotin, a B-complex vitamin, has been found to be an effective tool for slowing down multiple sclerosis (MS) in two clinical trials by MedDay Pharmaceuticals. According to a report on healthline.com, the vitamin also known as vitamin H could be used to treat both relapsing and progressive multiple sclerosis.

MORE: 12 ways Amazon’s Alexa can help people with multiple sclerosis

Trials of the vitamin discovered that it helps to strengthen myelin as well as provide energy for neurons. The first trial using 300 mg of high-quality biotin consisted of just 23 MS patients but showed significant improvements, the second test — a double-blind clinical trial — used 154 patients and again showed that biotin was useful in slowing down and improving disability in people living with progressive MS.

The company is now planning its phase 3 clinical trial using a larger study base involving 600 patients from the U.S. and Europe.

MORE: Six of the best apps for managing chronic illness

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

The Multiple Sclerosis Podcast


Survey Icon

Video